We have located links that may give you full text access.
Investigation of oxygen transfer rates in full scale membrane bioreactors.
In membrane bioreactors (MBRs) for wastewater treatment the secondary clarifier is replaced by a membrane filtration. The advantage of this process is a complete removal of solids from the effluent and a small footprint due to possible high biomass concentrations (MLSS). As oxygen supply counts for more than 70% of total energy cost in municipal WWTPs the design of the aeration system is vital for efficient operation. In this respect the alpha-value is an important influencing factor. The alpha-value depends on the MLSS-concentration as shown in various publications and confirmed by own measurements in two full scale municipal MBRs with MLSS ranging from 7 and 17 kg/m3. Furthermore it must be taken into account that alpha-values are not static values; they vary with loading rates, surfactant concentrations, air flow rates, MLSS concentrations, etc. The average alpha-value at typical 12 kg/m3 MLSS for municipal MBRs is about 0.6 +/- 0.1. As submerged configured MBRs are equipped with an additional coarse bubble "crossflow" aeration system for fouling control, supplementary energy is consumed. Therefore MBRs need more energy compared to conventional treatment plants. Measurements of both aeration systems show that the fine bubble aeration system is more efficient by a factor of three concerning oxygen supply compared to the coarse bubble system.
Full text links
Related Resources
Trending Papers
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Review article: Recent advances in ascites and acute kidney injury management in cirrhosis.Alimentary Pharmacology & Therapeutics 2024 March 26
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app